These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1337070)

  • 21. Treatment failure in erythema migrans--a review.
    Weber K
    Infection; 1996; 24(1):73-5. PubMed ID: 8852475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term serological follow-up of patients treated for chronic cutaneous borreliosis or culture-positive erythema migrans.
    Lomholt H; Lebech AM; Hansen K; Brandrup F; Halkier-Sørensen L
    Acta Derm Venereol; 2000; 80(5):362-6. PubMed ID: 11200835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of erythema migrans in pregnancy.
    Maraspin V; Cimperman J; Lotric-Furlan S; Pleterski-Rigler D; Strle F
    Clin Infect Dis; 1996 May; 22(5):788-93. PubMed ID: 8722932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis, treatment, and prognosis of erythema migrans and Lyme arthritis.
    Feder HM; Abeles M; Bernstein M; Whitaker-Worth D; Grant-Kels JM
    Clin Dermatol; 2006; 24(6):509-20. PubMed ID: 17113969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibiotic treatment of children with erythema migrans.
    Arnez M
    Clin Infect Dis; 2007 Apr; 44(8):1133-4; author reply 1137-9. PubMed ID: 17366464
    [No Abstract]   [Full Text] [Related]  

  • 26. Roxithromycin in Lyme borreliosis: discrepant results of an in vitro and in vivo animal susceptibility study and a clinical trial in patients with erythema migrans.
    Hansen K; Hovmark A; Lebech AM; Lebech K; Olsson I; Halkier-Sørensen L; Olsson E; Asbrink E
    Acta Derm Venereol; 1992 Aug; 72(4):297-300. PubMed ID: 1357894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of the early manifestations of Lyme disease.
    Steere AC; Hutchinson GJ; Rahn DW; Sigal LH; Craft JE; DeSanna ET; Malawista SE
    Ann Intern Med; 1983 Jul; 99(1):22-6. PubMed ID: 6407378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subjective symptoms after treatment of early Lyme disease.
    Cerar D; Cerar T; Ruzić-Sabljić E; Wormser GP; Strle F
    Am J Med; 2010 Jan; 123(1):79-86. PubMed ID: 20102996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple erythema migrans--manifestation of systemic cutaneous borreliosis.
    Egberts F; Möller M; Proksch E; Schwarz T
    J Dtsch Dermatol Ges; 2008 May; 6(5):350-3. PubMed ID: 18201222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical relevance of different IgG and IgM serum antibody responses to Borrelia burgdorferi after antibiotic therapy for erythema migrans: long-term follow-up study of 113 patients.
    Glatz M; Golestani M; Kerl H; Müllegger RR
    Arch Dermatol; 2006 Jul; 142(7):862-8. PubMed ID: 16847202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Doxycycline-induced photosensitivity in patients treated for erythema migrans.
    Velušček M; Bajrović FF; Strle F; Stupica D
    BMC Infect Dis; 2018 Aug; 18(1):365. PubMed ID: 30075748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Lyme borreliosis: How should erythema migrans be treated in pregnant women?].
    Schröder J; Kirch W
    Dtsch Med Wochenschr; 2009 Nov; 134(46):2354. PubMed ID: 19894205
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical spectrum of skin manifestations of Lyme borreliosis in 204 children in Austria.
    Glatz M; Resinger A; Semmelweis K; Ambros-Rudolph CM; Müllegger RR
    Acta Derm Venereol; 2015 May; 95(5):565-71. PubMed ID: 25366035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Penicillin V is the first choice in the treatment of erythema migrans].
    Bennet L; Stiernstedt S; Berglund J; Hagberg L; Karlsson M; Olsson I; Ornstein K
    Lakartidningen; 2006 May 3-9; 103(18):1454; author reply 1455. PubMed ID: 16729462
    [No Abstract]   [Full Text] [Related]  

  • 35. Is azithromycin treatment associated with prolongation of the Q-Tc interval?
    Strle F; Maraspin V
    Wien Klin Wochenschr; 2002 Jun; 114(10-11):396-9. PubMed ID: 12708094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Duration of antibiotic therapy for early Lyme disease. A randomized, double-blind, placebo-controlled trial.
    Wormser GP; Ramanathan R; Nowakowski J; McKenna D; Holmgren D; Visintainer P; Dornbush R; Singh B; Nadelman RB
    Ann Intern Med; 2003 May; 138(9):697-704. PubMed ID: 12729423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [First-choice treatment for erythema migrans is still penicillin].
    Eliassen KE; Lindbaek M; Berild D; Hjortdahl P; Fetveit A
    Tidsskr Nor Laegeforen; 2008 Aug; 128(15):1681; author reply 1681. PubMed ID: 18704139
    [No Abstract]   [Full Text] [Related]  

  • 38. Erythema migrans in the immunocompromised host.
    Maraspin V; Lotric-Furlan S; Cimperman J; Ruzić-Sabljić E; Strle F
    Wien Klin Wochenschr; 1999 Dec; 111(22-23):923-32. PubMed ID: 10666803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Stage-oriented treatment of Lyme borreliosis].
    Fingerle V; Wilske B
    MMW Fortschr Med; 2006 Jun; 148(25):39-41. PubMed ID: 16859159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is Doxycycline Appropriate for Routine Treatment of Young Children With Erythema Migrans?
    Wormser GP; Strle F; Shapiro ED
    Pediatr Infect Dis J; 2019 Nov; 38(11):1113-1114. PubMed ID: 31626045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.